Role of ACSL4 in modulating farnesoid X receptor expression and M2 macrophage polarization in HBV‐induced hepatocellular carcinoma

Abstract

Abstract The intricate relationship between bile acid (BA) metabolism, M2 macrophage polarization, and hepatitis B virus‐hepatocellular carcinoma (HBV‐HCC) necessitates a thorough investigation of ACSL4's (acyl‐CoA synthetase long‐chain family member 4) role. This study combines advanced bioinformatics and experimental methods to elucidate ACSL4's significance in HBV‐HCC development. Using bioinformatics, we identified differentially expressed genes in HBV‐HCC. STRING and gene set enrichment analysis analyses were employed to pinpoint critical genes and pathways. Immunoinfiltration analysis, along with in vitro and in vivo experiments, assessed M2 macrophage polarization and related factors. ACSL4 emerged as a pivotal gene influencing HBV‐HCC. In HBV‐HCC liver tissues, ACSL4 exhibited upregulation, along with increased levels of M2 macrophage markers and BA. Silencing ACSL4 led to heightened farnesoid X receptor (FXR) expression, reduced BA levels, and hindered M2 macrophage polarization, thereby improving HBV‐HCC conditions. This study underscores ACSL4's significant role in HBV‐HCC progression. ACSL4 modulates BA‐mediated M2 macrophage polarization and FXR expression, shedding light on potential therapeutic targets and novel insights into HBV‐HCC pathogenesis.

Keywords

• ACSL4
• bile acid metabolism
• farnesoid X receptor
• hepatitis B virus‐hepatocellular carcinoma
• M2 macrophage polarization